Zobrazeno 1 - 8
of 8
pro vyhledávání: '"FTC, fumitremorgin C"'
Autor:
Fanpu Zeng, Qian Han, Hong Zhang, Fang Wang, Zhen Chen, Zongheng Zheng, Kenneth K.W. To, Liwu Fu
Publikováno v:
Acta Pharmaceutica Sinica. B
Acta Pharmaceutica Sinica B, Vol 10, Iss 5, Pp 799-811 (2020)
Acta Pharmaceutica Sinica B, Vol 10, Iss 5, Pp 799-811 (2020)
Overexpression of adenosine triphosphate (ATP)-binding cassette subfamily G member 2 (ABCG2) in cancer cells is known to cause multidrug resistance (MDR), which severely limits the clinical efficacy of chemotherapy. Currently, there is no FDA-approve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c640b876016d2964b38275e93078575
http://europepmc.org/articles/PMC7280144
http://europepmc.org/articles/PMC7280144
Autor:
Skyler Kuhn, Michael M Gottesman, Frances Maher, Da Yin, Robert W. Robey, Jordan M. Hotz, Sachi Horibata, Ruchi P. Patel
Publikováno v:
Translational Oncology
Translational Oncology, Vol 14, Iss 1, Pp 100917-(2021)
Translational Oncology, Vol 14, Iss 1, Pp 100917-(2021)
Highlights • Subpopulations of cisplatin-resistant cells are cross-resistant to anti-microtubule drugs. • Resistance mechanisms in cisplatin-resistant ovarian cancer cells are diverse. • Increased TNF and NFκB signaling found in cisplatin-resi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::636ba93dc8cc9508c9c866f6ce289f2c
http://europepmc.org/articles/PMC7586247
http://europepmc.org/articles/PMC7586247
Publikováno v:
Acta Pharmaceutica Sinica. B
Precision medicine is a rapidly-developing modality of medicine in human healthcare. Based on each patient׳s unique characteristics, more accurate dosages and drug selection can be made to achieve better therapeutic efficacy and less adverse reactio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d21030ccc922a2c60ef93a66ef52208b
https://pubmed.ncbi.nlm.nih.gov/31384528
https://pubmed.ncbi.nlm.nih.gov/31384528
Autor:
Zhiqiang, Zhang, Xiaoran, Guo, Kenneth K W, To, Zhen, Chen, Xiaona, Fang, Min, Luo, Chunling, Ma, Jianhua, Xu, Shirong, Yan, Liwu, Fu
Publikováno v:
Acta Pharmaceutica Sinica. B
Overexpressing of ATP-binding cassette (ABC) transporters is the essential cause of multidrug resistance (MDR), which is a significant hurdle to the success of chemotherapy in many cancers. Therefore, inhibiting the activity of ABC transporters may b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::55c56cc9b202781bd5b272f8d90ee3e2
https://pubmed.ncbi.nlm.nih.gov/30109181
https://pubmed.ncbi.nlm.nih.gov/30109181
Autor:
Maliyakkal N; Department of Basic Medical Sciences, College of Applied Medical Sciences in Khamis Mushait, King Khalid University, Abha, Saudi Arabia.; Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka, India.; Cancer Research Unit, King Khalid University, Abha, Saudi Arabia., Appadath Beeran A; Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka, India., Udupa N; Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka, India.
Publikováno v:
Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society [Saudi Pharm J] 2021 Aug; Vol. 29 (8), pp. 857-873. Date of Electronic Publication: 2021 Jul 15.
Autor:
Zeng F; The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510000, China.; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Guangdong Esophageal Cancer Institute, Sun Yat-sen University Cancer Center, Guangzhou 510060, China., Wang F; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Guangdong Esophageal Cancer Institute, Sun Yat-sen University Cancer Center, Guangzhou 510060, China., Zheng Z; The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510000, China., Chen Z; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Guangdong Esophageal Cancer Institute, Sun Yat-sen University Cancer Center, Guangzhou 510060, China., Wah To KK; School of Pharmacy, Faculty of Medicine, the Chinese University of Hong Kong, Hong Kong, SAR, China., Zhang H; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Guangdong Esophageal Cancer Institute, Sun Yat-sen University Cancer Center, Guangzhou 510060, China., Han Q; Guangzhou Handy Biotechnological Co., Ltd., Guangzhou 511400, China., Fu L; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Guangdong Esophageal Cancer Institute, Sun Yat-sen University Cancer Center, Guangzhou 510060, China.
Publikováno v:
Acta pharmaceutica Sinica. B [Acta Pharm Sin B] 2020 May; Vol. 10 (5), pp. 799-811. Date of Electronic Publication: 2020 Jan 26.
Autor:
Chen L; Department of Pharmaceutical Sciences, School of Pharmacy, University of Connecticut, Storrs, CT 06269, USA., Manautou JE; Department of Pharmaceutical Sciences, School of Pharmacy, University of Connecticut, Storrs, CT 06269, USA., Rasmussen TP; Department of Pharmaceutical Sciences, School of Pharmacy, University of Connecticut, Storrs, CT 06269, USA., Zhong XB; Department of Pharmaceutical Sciences, School of Pharmacy, University of Connecticut, Storrs, CT 06269, USA.
Publikováno v:
Acta pharmaceutica Sinica. B [Acta Pharm Sin B] 2019 Jul; Vol. 9 (4), pp. 659-674. Date of Electronic Publication: 2019 Jan 15.
Autor:
Zhang Z; Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China.; School of Pharmacy, Fujian Medical University, Fuzhou 350108, China., Guo X; Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China.; Hubei University of Medicine, Shiyan 442000, China., To KKW; School of Pharmacy, Faculty of Medicine, the Chinese University of Hong Kong, Hong Kong, China., Chen Z; Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China., Fang X; Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China., Luo M; Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China., Ma C; Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China.; School of Pharmacy, Fujian Medical University, Fuzhou 350108, China., Xu J; School of Pharmacy, Fujian Medical University, Fuzhou 350108, China., Yan S; Hubei University of Medicine, Shiyan 442000, China., Fu L; Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China.
Publikováno v:
Acta pharmaceutica Sinica. B [Acta Pharm Sin B] 2018 Jul; Vol. 8 (4), pp. 563-574. Date of Electronic Publication: 2018 Jun 15.